| __timestamp | MiMedx Group, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 90480000 | 24518692 |
| Thursday, January 1, 2015 | 133384000 | 19886580 |
| Friday, January 1, 2016 | 179997000 | 12631689 |
| Sunday, January 1, 2017 | 220119000 | 21977998 |
| Monday, January 1, 2018 | 258528000 | 20759000 |
| Tuesday, January 1, 2019 | 198205000 | 20838000 |
| Wednesday, January 1, 2020 | 181022000 | 121812000 |
| Friday, January 1, 2021 | 198359000 | 152137000 |
| Saturday, January 1, 2022 | 208789000 | 83231000 |
| Sunday, January 1, 2023 | 211124000 | 122706000 |
Unleashing the power of data
In the ever-evolving landscape of the pharmaceutical industry, understanding the financial strategies of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of TG Therapeutics, Inc. and MiMedx Group, Inc. from 2014 to 2023. Over this period, MiMedx Group consistently outspent TG Therapeutics, with SG&A expenses peaking at approximately 258 million in 2018. In contrast, TG Therapeutics saw a significant rise in 2021, with expenses reaching around 152 million, marking a 600% increase from 2014. This trend highlights MiMedx's aggressive market strategy, while TG Therapeutics' recent surge suggests a shift towards expansion. As the industry continues to grow, these financial insights provide a window into the strategic priorities of these companies, offering investors and analysts a deeper understanding of their operational dynamics.
SG&A Efficiency Analysis: Comparing Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs TG Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and MiMedx Group, Inc.
SG&A Efficiency Analysis: Comparing Opthea Limited and MiMedx Group, Inc.
Operational Costs Compared: SG&A Analysis of TG Therapeutics, Inc. and Verona Pharma plc
TG Therapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or Galapagos NV
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Xencor, Inc. Trends and Insights
Breaking Down SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs MiMedx Group, Inc.
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and MiMedx Group, Inc.
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and MiMedx Group, Inc.
Comparing SG&A Expenses: Soleno Therapeutics, Inc. vs MiMedx Group, Inc. Trends and Insights